Skip to main content

Prothea Technologies

Edinburgh, United Kingdom

Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.

$13.0M raised
Apr 2024
Series A

Top Investors

Earlybird Venture CapitalMerieux Equity PartnersNRW.BANKOld College Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prothea Technologies

How much funding has Prothea Technologies raised?
Prothea Technologies has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Who are Prothea Technologies's investors?
Prothea Technologies's investors include Earlybird Venture Capital, Merieux Equity Partners, NRW.BANK, Old College Capital.
Where is Prothea Technologies headquartered?
Prothea Technologies is headquartered in Edinburgh, United Kingdom.
What does Prothea Technologies do?
Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
What stage is Prothea Technologies at?
Prothea Technologies is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Prothea Technologies — Funding & Investors." VCBacked, April 9, 2024, https://www.vcbacked.co/company/prothea-technologies. Accessed June 3, 2026.
APA
VCBacked. (2024). Prothea Technologies — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/prothea-technologies
Wikipedia (cite web)
{{cite web |title=Prothea Technologies — Funding & Investors |url=https://www.vcbacked.co/company/prothea-technologies |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .